High-Dose Inactivated Influenza Vaccine Is Associated With Cost Savings And Better Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Seniors
Abstract
Authors
A. Chit D.L. Becker C. Diazgranados M. Maschio E. Yau M. Drummond